AVONEX® has been prescribed as an injectable treatment for relapsing multiple sclerosis (MS) to over 590,000 people since its approval in 1996. Get Important Safety Information.
| Website | http://www.avonex.com |
| Revenue | $6 million |
| Employees | View employees |
| Address | 225 Binney St, Cambridge, Massachusetts 02142, US |
| Phone | +1 800-456-2255 |
| Industry | Manufacturing General, Manufacturing |
| Competitors | Roche, Novartis, AbbVie, The Janssen Pharmaceutical Companies of Johnson & Johnson, Merck & Co., Inc., Pfizer, Sanofi, Bristol Myers Squibb, Genentech, Biogen +38 more (view full list) |
| SIC | SIC Code 283 Companies, SIC Code 28 Companies |
| NAICS | NAICS Code 32541 Companies, NAICS Code 325 Companies, NAICS Code 32 Companies, NAICS Code 3254 Companies |
Looking for a particular Avonex employee's phone or email?
The Avonex annual revenue was $6 million in 2026.
Avonex is based in Cambridge, Massachusetts.
The NAICS codes for Avonex are [32541, 325, 32, 3254].
The SIC codes for Avonex are [283, 28].